Aligarh Muslim University (AMU) has entered into a Public-Private Partnership (PPP) with Molecular Diagnostics and Therapy to establish a state-of-the-art Oncology and Advanced Diagnostic Centre at the Cancer OPD block, Department of Radio Therapy, Jawaharlal Nehru Medical College (JNMC), marking a significant step towards strengthening cancer care and advanced diagnostics in the region.

The Memorandum of Understanding was signed between Dr. Nikunj Jain - Co-Founder and HOD - Molecular Diagnostics and Therapy, Team Molecular and AMU Registrar Prof Aasim Zafar in the presence of the Vice Chancellor, Prof Naima Khatoon, Pro-Vice Chancellor Prof Mohd Mohsin Khan, Dean, Faculty of Medicine Prof Mohammad Khalid, Principal, J.N. Medical College Prof Anjum Parvez, Finance Officer Mr Noorus Salam, Chairman, Department of Radiotherapy Prof Mohammad Akram. 

Speaking on the occasion, Vice Chancellor Prof Naima Khatoon said, “This partnership reflects AMU’s commitment to making advanced and affordable healthcare accessible to the people of Aligarh and neighbouring districts. By combining academic excellence with cutting-edge technology, the University aims to ensure that world-class cancer diagnosis and treatment are available closer to home.”

Chairman, Department of Radiotherapy, Prof Mohammad Akram said that the collaboration represents a shared commitment to translating academic expertise into meaningful clinical outcomes. He noted that the real value of the MoU lies in its implementation, which would strengthen clinical services, enhance training opportunities for students and residents, and create a sustainable model of academia–healthcare collaboration benefiting both patients and the community.

Under the partnership, the centre will introduce North India’s first new-age digital radio therapy platform based on advanced Linear Accelerator (LINAC) technology, along with digital PET/CT and gamma camera imaging facilities for early diagnosis of complex medical conditions. The project also envisages comprehensive radionuclide therapy services, including specialised treatment for thyroid cancer and other advanced oncological disorders.

The collaboration will also support academics and research by providing AMU students and faculty hands-on exposure to advanced diagnostic and therapeutic technologies, while maintaining full academic autonomy of the University. The facility will serve as a hub for clinical research and will extend services under government health schemes such as Ayushman Bharat, ECHS, ESI and CGHS, ensuring equitable access to quality healthcare.